Search company, investor...

FoxBio

Total Raised

$10M

Investors Count

Funding, Valuation & Revenue

2 Fundings

FoxBio has raised $10M over 2 rounds.

FoxBio's latest funding round was a Corporate Minority - II for on July 25, 2018.

Date	Round	Amount	Investors	Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.	Revenue	Sources
7/25/2018	Corporate Minority - II		Antoxerene	$99M	0 FY undefined	1
7/25/2018	Corporate Minority	$99M	Subscribe to see more	$99M	0 FY undefined	10

Date	7/25/2018	7/25/2018
Round	Corporate Minority - II	Corporate Minority
Amount		$99M
Investors	Antoxerene	Subscribe to see more
Valuation	$99M	$99M
Revenue	0 FY undefined	0 FY undefined
Sources	1	10

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.

Click Now. Join a live demo

Looking for a leg up on competitive, customer and technology insights?

CB Insights puts confidence and clarity into your most strategic decisions.

See how. Join a demo.

Trusted by the world's smartest companies to:

Predict emerging trends
See competitors' playbooks
Stalk the smart money
Identify tomorrow's challengers
Spot growing industries
Kill analyst data work

Let's see how we can help you!

FoxBio Investors

2 Investors

FoxBio has 2 investors. Antoxerene invested in FoxBio's Corporate Minority - II funding round.

First funding	Last Funding	Investor	Rounds	Board Seats	Type	Location
7/25/2018	7/25/2018	Antoxerene	1 Corporate Minority - II		Corporation	New York
00/00/0000	00/00/0000	Juvenescence	Subscribe to see more		Corporation	New Jersey

First funding	7/25/2018	00/00/0000
Last Funding	7/25/2018	00/00/0000
Investor	Antoxerene	Juvenescence
Rounds	1 Corporate Minority - II	Subscribe to see more
Board Seats
Type	Corporation	Corporation
Location	New York	New Jersey